Segmed, which deidentifies and standardizes medical imaging data for artificial intelligence development and clinical research, said it plans to use the investment to further expand into healthcare AI as well as biopharmaceuticals and life sciences.
“We’re driven to advance the science of medicine,” said Emilie McKenna, managing director of strategic development and investment at Advocate Health, in a Sept. 3 statement. “To that end, our team is dedicated to developing the most comprehensive provider-based research dataset in the country.”
The oversubscribed series A funding round was co-led by healthcare venture capital firm iGan Partners and also included Philadelphia-based Fox Chase Cancer Center.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
